We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Teva’s Marth Discusses FOBs, Other Initiatives for 2009
Teva’s Marth Discusses FOBs, Other Initiatives for 2009
February 17, 2009
William Marth, Teva North America’s president and CEO, is urging Congress to set a shorter data exclusivity period for biologics.